Ascendis Pharma A/S Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement
Ascendis Pharma A/S (ASND) had Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement of 522259100.00% as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement · last filed 2026-02-11
- 2025-12-31: Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement 522259100.00%.
- 2024-12-31: Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement 620412200.00%.
- 2024-03-31: Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement 122695800.00%.
- 2023-12-31: Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement 652378400.00%.
| Period end | Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement |
|---|---|
| 2025-12-31 | 522259100.00% 20-F · filed 2026-02-11 |
| 2024-12-31 | 620412200.00% 20-F · filed 2025-02-12 |
| 2024-03-31 | 122695800.00% 6-K · filed 2024-05-02 |
| 2023-12-31 | 652378400.00% 20-F · filed 2024-02-07 |
| 2022-12-31 | 686401100.00% 20-F · filed 2023-02-16 |
| 2021-12-31 | 708507300.00% 20-F · filed 2022-03-02 |
| 2019-12-31 | 582021100.00% 20-F · filed 2020-04-03 |
| 2018-12-31 | 561162900.00% 20-F · filed 2019-04-03 |
| 2017-12-31 | 462115400.00% 20-F · filed 2018-03-28 |
| 2016-12-31 | 369176500.00% 20-F · filed 2018-03-28 |
| 2015-12-31 | 261590300.00% 20-F · filed 2018-03-28 |